FDA Defends Zohydro Approval as State Prosecutors Pile On Criticism

Drug Industry Daily
A A
As more critics of the FDA’s approval of the painkiller Zohydro ER come forward, the agency says it will not limit approval of new opioid painkillers to those with abuse-deterrent properties.

To View This Article:

Login

Subscribe To Drug Industry Daily